Ibandronic Acid Teva 150 mg Film-Coated Tablets EFG
ibandronic acid
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Ibandronic Acid Teva belongs to a group of medicines called bisphosphonates and contains ibandronic acid. Ibandronic Acid Teva can reverse bone loss because it prevents further bone loss and increases bone mass in most women who take it, even if they cannot see or feel the difference. Ibandronic Acid Teva may help reduce the risk of bone fractures. This reduction has been shown in spinal fractures but not in hip fractures.
You have been prescribed Ibandronic Acid Teva to treat your postmenopausal osteoporosis because you are at high risk of fractures. Osteoporosis is a condition where bones become thinner and weaker, which is common in women after the menopause. During the menopause, the ovaries stop producing the female hormone - oestrogen - which helps to keep the bones healthy.
The earlier a woman reaches the menopause, the greater her risk of fractures due to osteoporosis.
Other factors that increase the risk of fractures include:
Healthy lifestyle habits also help the beneficial effects of treatment. These include a balanced diet rich in calcium and vitamin D; walking or other weight-bearing exercise; not smoking and not drinking too much alcohol.
Do not take Ibandronic Acid Teva
Warnings and precautions
A rare side effect has been reported with this medicine called osteonecrosis of the jaw (ONJ) (bone damage in the jaw). This has been reported in patients taking Ibandronic Acid Teva for osteoporosis.
It is very important to try to prevent ONJ as it can be a painful condition that can be difficult to treat. To reduce the risk of developing osteonecrosis of the jaw, certain precautions need to be taken.
Atypical fractures of the long bones in the legs have also been reported with long-term use of ibandronate. These fractures can occur with little or no trauma and some patients experience pain in the area of the fracture before a complete fracture occurs.
Before receiving treatment, inform your doctor/nurse (healthcare professional) if:
Your doctor may ask you to have a dental check-up before starting treatment with Ibandronic Acid Teva.
While you are being treated, you should maintain good oral hygiene (including regular tooth brushing) and have regular dental check-ups. If you wear dentures, you should make sure they fit properly. If you are having dental treatment or are about to have a dental operation (e.g. tooth extraction), inform your doctor about your dental treatment and inform your dentist that you are being treated with Ibandronic Acid Teva.
Contact your doctor and dentist immediately if you experience any problems with your mouth or teeth, such as loose teeth, pain or swelling, or difficulty healing after a mouth ulcer or discharge, as these could be signs of osteonecrosis of the jaw.
Certain people need to take special care with Ibandronic Acid Teva. Talk to your doctor before taking Ibandronic Acid Teva:
You may experience irritation, inflammation or ulceration of the oesophagus (the tube that connects your mouth and stomach) sometimes with symptoms of severe chest pain after eating or drinking, severe nausea or vomiting, especially if you have not drunk a full glass of water and/or if you have lain down within an hour of taking Ibandronic Acid Teva. If you develop these symptoms, stop taking Ibandronic Acid Teva and inform your doctor immediately (see section 3).
Children and adolescents:
Ibandronic Acid Teva should not be used in children and adolescents below 18 years.
Other medicines and Ibandronic Acid Teva
Inform your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Especially:
After taking the Ibandronic Acid Teva monthly tablet, wait 1 hour before taking any other medicine, including antacids, calcium supplements or vitamins.
Ibandronic Acid Teva with food and drink
Do not take Ibandronic Acid Teva with food. Ibandronic Acid Teva loses its effect if taken with food.
You can drink water but not other drinks.
After taking Ibandronic Acid Teva, wait 1 hour before taking your first food and other drinks. How to take Ibandronic Acid Teva).
Pregnancy and breastfeeding
Ibandronic Acid Teva is for use in postmenopausal women only and should not be taken by women of childbearing potential.
Do not take Ibandronic Acid Teva if you are pregnant or breastfeeding. If you are breastfeeding, you may need to stop in order to take Ibandronic Acid Teva.
Consult your doctor or pharmacist before using this medicine.
Driving and using machines
Ibandronic Acid Teva is not expected to have any effect on the ability to drive and use machines.
Ibandronic Acid Teva contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per film-coated tablet; this is essentially “sodium-free”.
Always take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
The usual dose of Ibandronic Acid Teva is one tablet once a month.
How to take the monthly tablet
It is very important that you follow these instructions carefully. They are designed to help Ibandronic Acid Teva reach the stomach quickly and cause less irritation.
Do nottake the tablet with water with high calcium levels, fruit juice or other drinks. If your tap water contains high levels of calcium, it is recommended to use bottled water with low mineral content.
Continuation of treatment with Ibandronic Acid Teva
It is important that you take Ibandronic Acid Teva every month, for as long as your doctor prescribes it.
After 3 - 5 years of taking Ibandronic Acid Teva, consult your doctor to see if you should continue taking Ibandronic Acid Teva.
If you take more Ibandronic Acid Teva than you should
If you accidentally take too many tablets, drink a full glass of milk and contact your doctor immediately. Do not induce vomiting and do not lie down because Ibandronic Acid Teva could irritate your oesophagus
If you forget to take Ibandronic Acid Teva
If you forget to take the tablet on the morning of the day you have chosen, do not take the tablet later.
Instead, consult your calendar to see when your next dose is due
Never take two Ibandronic Acid Teva tablets within the same week. Wait until your next scheduled dose and take it as usual, then continue taking one tablet per month according to the days marked on your calendar.
Take a tablet the next morning after the day you remember you forgot the dose, then continue taking one tablet per month according to the days marked on your calendar.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor or nurse immediately if you notice any of the following serious side effects, as you may need urgent medical treatment:
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
difficulty breathing
Very rare (may affect up to 1 in 10,000 people)
Other possible side effects
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after “EXP”. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Teva Ibandronic Acid
Each film-coated tablet contains 150 mg of ibandronic acid (as sodium monohydrate salt)
tablet core: microcrystalline cellulose, povidone K-A), anhydrous colloidal silica and stearic acid;
tablet coating: titanium dioxide (E171), hypromellose, macrogol 400 and polysorbate 80.
Appearance of the product and container contents
The film-coated tablets of Teva Ibandronic Acid are white, biconvex, capsule-shaped and engraved with "I150" on one side and smooth on the other
Teva Ibandronic Acid is available in blisters (PVC/Aclar/PVC - Aluminum) in packs of 1 and 3 tablets
Only some pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder and manufacturer
Teva B.V.
Swensweg 5
Netherlands
Manufacturer:
Teva Pharmaceutical Works Private Limited Company
Pallagi ut 13
4042 Debrecen
Hungary
Pharmachemie B.V.
Swensweg 5,
2031 GA Haarlem
Netherlands
Teva Czech Industries s.r.o
Ostravka 29/305
747 70 Opava-Komarov
Czech Republic
Teva Operations Poland Sp.z o.o
ul.Mogilska 80
31-546 Krakow
Poland
For more information about this medicinal product, please contact the local representative of the marketing authorization holder:
België/Belgique/Belgien Teva Pharma Belgium N.V./S.A./AG Tél/Tel: +32 38207373 | Lietuva UAB Teva Baltics Tel: +370 52660203 |
Luxembourg/Luxemburg Teva Pharma Belgium N.V./S.A./AG Belgique/Belgien Tél/Tel: +32 38207373 | |
Ceská republika Teva Pharmaceuticals CR, s.r.o. Tel: +420 251007111 | Magyarország Teva Gyógyszergyár Zrt. Tel: +36 12886400 |
Danmark Teva Denmark A/S Tlf: +45 44985511 | Malta Teva Pharmaceuticals Ireland Ireland Tel: +44 2075407117 |
Deutschland TEVA GmbH Tel: +49 73140208 | Nederland Teva Nederland B.V. Tel: +31 8000228400 |
Eesti UAB Teva Baltics Eesti filiaal Tel: +372 6610801 | Norge Teva Norway AS Tlf: +47 66775590 |
Ελλáδα Specifar A.B.E.E. Τηλ: +30 2118805000 | Österreich ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1970070 |
España Teva Pharma, S.L.U. Tel: +34 913873280 | Polska Teva Pharmaceuticals Polska Sp. z o.o. Tel: +48 223459300 |
France Teva Santé Tél: +33 155917800 | Portugal Teva Pharma - Produtos Farmacêuticos, Lda. Tel: +351 214767550 |
Hrvatska Pliva Hrvatska d.o.o. Tel: +385 13720000 | România Teva Pharmaceuticals S.R.L. Tel: +40 212306524 |
Ireland Teva Pharmaceuticals Ireland Tel: +44 2075407117 | Slovenija Pliva Ljubljana d.o.o. Tel: +386 15890390 |
Ísland Teva Pharma Iceland ehf. Sími: +354 5503300 | Slovenská republika TEVA Pharmaceuticals Slovakia s.r.o. Tel: +421 257267911 |
Italia Teva Italia S.r.l. Tel: +39 028917981 | Suomi/Finland Teva Finland Oy Puh/Tel: +358 201805900 |
Κ?προς TEVA HELLAS A.E. Ελλ?δα Τηλ: +30 2118805000 | Sverige Teva Sweden AB Tel: +46 42121100 |
Latvija UAB Teva Baltics filiale Latvija Tel: +371 67323666 | United Kingdom (Northern Ireland) Teva Pharmaceuticals Ireland Ireland Tel: +44 2075407117 |
Date of last revision of this leaflet: {MM/AAAA}
Detailed information on this medicinal product is available on the European Medicines Agency website http://www.ema.europa.eu.
The average price of IBANDRONIC ACID TEVA 150 mg FILM-COATED TABLETS in October, 2025 is around 13 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.